Abnova Taiwan Corp
TWSE:4133

Watchlist Manager
Abnova Taiwan Corp Logo
Abnova Taiwan Corp
TWSE:4133
Watchlist
Price: 22.35 TWD -0.22% Market Closed
Market Cap: 1.4B TWD

Abnova Taiwan Corp
Investor Relations

Abnova Taiwan Corp. is engaged in researching, developing, manufacturing and selling antibodies. The company is headquartered in Taipei City, Taipei. The company went IPO on 2008-05-27. The firm's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The firm's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.

Show more
Loading
4133
Taiwan Weighted Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Yi Huang Huang
Deputy General Manager
No Bio Available

Contacts

Address
TAIPEI
Taipei City
9F, No.108, Jhouzih Street, Si Hu Li, Neihu District
Contacts
+886287511888
www.abnova.com